Médica Sur, S.A.B. de C.V. (MEDICAB.MX)
- Previous Close
41.00 - Open
41.00 - Bid 42.00 x 137500
- Ask 42.10 x 5500
- Day's Range
41.00 - 42.00 - 52 Week Range
27.30 - 43.25 - Volume
44,502 - Avg. Volume
6,153 - Market Cap (intraday)
4.007B - Beta (5Y Monthly) 0.55
- PE Ratio (TTM)
10.74 - EPS (TTM)
3.91 - Earnings Date --
- Forward Dividend & Yield 1.50 (3.57%)
- Ex-Dividend Date May 19, 2025
- 1y Target Est
72.97
Médica Sur, S.A.B. de C.V. operates as a healthcare hospital in Mexico. The company offers angiology, vascular, and endovascular surgery; bariatric surgery; cancer; cardiology; checkup and preventive medicine; children; dental; emergency; endocrinology; gastroenterology, hepatology, and endoscopy; general surgery; geriatric; and gynecology and obstetrics services. It also provides specialized surgery; neonatology; neurology, neurosurgery, and gamma knife radiosurgery; neurophysiology; nuclear medicine; orthopedic and traumatology; outpatient surgery; plastic surgery; robotic surgery; spine microsurgery; transplant; urology; vascular disease; and imagine and MRI unit services. In addition, the company offers accommodation; concierge; digital hospital and telemedicine; gourmet; assistance in paperwork and filing procedures with insurer; and tour and transportation services. Further, it provides medical services and diagnosis. The company was incorporated in 1966 and is based in Mexico City, Mexico. Médica Sur, S.A.B. de C.V. is a subsidiary of Neuco, SAPI de CV.
www.medicasur.com.mx2,182
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: MEDICAB.MX
View MorePerformance Overview: MEDICAB.MX
Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is S&P/BMV IPC (^MXX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MEDICAB.MX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MEDICAB.MX
View MoreValuation Measures
Market Cap
4.01B
Enterprise Value
3.91B
Trailing P/E
10.74
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.00
Price/Book (mrq)
1.61
Enterprise Value/Revenue
0.89
Enterprise Value/EBITDA
4.53
Financial Highlights
Profitability and Income Statement
Profit Margin
10.64%
Return on Assets (ttm)
8.32%
Return on Equity (ttm)
19.07%
Revenue (ttm)
4.53B
Net Income Avi to Common (ttm)
442.9M
Diluted EPS (ttm)
3.91
Balance Sheet and Cash Flow
Total Cash (mrq)
1.31B
Total Debt/Equity (mrq)
41.31%
Levered Free Cash Flow (ttm)
527.44M